Ethinylestradiol/drospirenone

Ethinylestradiol/drospirenone
	Ethinylestradiol
	Drospirenone
Combination of
Ethinylestradiol	Estrogen
Drospirenone	Progestogen; Progestin; Antimineralocorticoid; Antiandrogen
Clinical data
Trade names	With 30 μg ethinylestradiol: Yasmin, others; With 20 μg ethinylestradiol: Yaz, Yasminelle, others
Other names	EE/DRSP; drospirenone/estradiol; drospirenone/ethinyl estradiol
AHFS/Drugs.com	Professional Drug Facts
MedlinePlus	a601050
License data	US DailyMed: Drospirenone and estradiol;
Pregnancy; category	AU: B3;
Routes of; administration	By mouth
ATC code	G03FA17 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only); US: ℞-only;
Identifiers
CAS Number	164017-31-6;
KEGG	D09741;

Ethinylestradiol/drospirenone (EE/DRSP), sold under the brand name Yasmin among others, is a combination of ethinylestradiol (EE), an estrogen, and drospirenone (DRSP), a progestin, antimineralocorticoid, and antiandrogen, which is used as a birth control pill to prevent pregnancy in women.^[6]^[7]^[4]^[5]^[8] It is also indicated for the treatment of moderate acne, premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and dysmenorrhea (painful menstruation) in women.^[7] The medication is taken by mouth and contains 30 μg EE and 3 mg DRSP per tablet (brand names Yasmin, others) or 20 μg EE and 3 mg DRSP per tablet (brand names Yaz, Yasminelle, Nikki, others).^[4]^[5] A formulation with levomefolic acid (vitamin B₉) has also been marketed (brand names Beyaz, Safyral, others), with similar indications.^[9]^[10] EE/DRSP is marketed widely throughout the world.^[11]

Quick Facts Combination of, Drospirenone ...

In 2022, it was the 142nd most commonly prescribed medication in the United States, with more than 4 million prescriptions.^[12]^[13]

See also